Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Fuzheng 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Immune Deficiency Syndrome Virus
1 trial -
GE Logiq E10 clinical ultrasound scanner
United Therapeutics Europe Ltd
Breast Tumor
1 trial -
GLP-1 Receptor Agonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Short Bowel Syndrome (SBS)
1 trial -
Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
United Therapeutics Europe Ltd
Maturity-onset Diabetes of the Young
1 trial -
GnRH-a-1M
The First People's Hospital of Lianyungang
Adenomyosis of Uterus
1 trial -
HLA-B*5801 test
BRIGHT MINDS BIOSCIENCES INC.
Stevens-Johnson Syndrome
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Innovative Dietary Formulation (Patent ID: CN110250417A)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
JY231 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
B-cell Malignancies
1 trial -
LCAR-M61S cells preparation
Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
1 trial -
LOC387715/HTRA1 genotyping
Hospital Authority, Hong Kong
Age-Related Macular Degeneration
1 trial -
Lactobacillus rhamnosus F-1
Biotech Pharmaceutical Co.,
Allergic Rhinitis
1 trial -
Low dose Radiotherapy
United Therapeutics Europe Ltd
Covid19
1 trial -
Lubiprostone
Takeda
Diabetes Mellitus, Type 1
1 trial -
Lugol's Solution (1.5%)
Hospital Authority, Hong Kong
Esophageal Squamous Cell Neoplasm
1 trial -
Manuka honey MGO 1000
United Therapeutics Europe Ltd
Post Surgical Pain
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
NanoDOX 1% doxycycline monohydrate Hydrogel
United Therapeutics Europe Ltd
Dehisced Surgical Wounds
1 trial -
Nitazoxanide Tablets
Vera Therapeutics
COVID-19
1 trial -
Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mental Health Wellness 1
1 trial -
P2Y12 antagonist monotherapy
Vera Therapeutics
Coronary Artery Disease
1 trial -
PD1-BCMA-CART
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
PG102P
Hospital Authority, Hong Kong
Uremic Pruritus
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources